Mode
Text Size
Log in / Sign up

Pilot Abstract Reports Artificial Baroreflex System With DBS in Parkinson Disease Patients

Pilot Abstract Reports Artificial Baroreflex System With DBS in Parkinson Disease Patients
Photo by Ben Maffin / Unsplash
Key Takeaway
Recognize that clinical efficacy is not established in larger trials for this pilot study involving 3 patients.

This publication is an abstract describing a pilot study involving 3 patients with Parkinson disease treated with deep brain stimulation (DBS). The intervention utilized an artificial baroreflex system algorithm aimed at managing orthostatic hypotension. Study phase and setting were not reported.

Primary outcomes assessed the frequency response of arterial pressure to DBS. Identifiable frequency response of systolic arterial pressure to random DBS was observed in all 3 trials, showing a steady state gain of 8.24 mmHg/STM. Secondary outcomes included computer simulation of AP drop attenuation, where the system could quickly and effectively attenuate a sudden AP drop induced by external disturbances such as head-up tilting.

The authors note low certainty due to the small sample size of n=3 and reliance on simulation for clinical efficacy. Safety data regarding adverse events, serious adverse events, discontinuations, and tolerability were not reported. Study design limits causal inference for clinical outcomes, and simulation results do not guarantee clinical performance.

Practice relevance suggests an artificial baroreflex system with DBS may be a novel therapeutic approach for orthostatic hypotension caused by central baroreflex failure. However, clinical efficacy is not established in larger trials.

Funding or conflicts of interest were not reported. The evidence remains preliminary given the pilot nature of the investigation.

Study Details

Sample sizen = 3
EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
Background: Deep brain stimulation (DBS) is a treatment option for Parkinson disease (PD). However, the effect of DBS on the arterial pressure (AP) remains unexplored. We aimed to develop an artificial baroreflex system for treating orthostatic hypotension (OH) due to central baroreflex failure in patients with PD. To achieve this, we developed an appropriate algorithm after estimating the dynamic responses of the AP to DBS using a white noise system identification method. Methods: We randomly performed DBS while measuring the AP tonometrically in 3 trials involving 3 patients with PD treated with DBS. We calculated the frequency response of the AP to the DBS using a fast Fourier transform algorithm. Finally, the feedback correction factors were determined via numerical simulation. Results: The frequency responses of the systolic AP to random DBS were identifiable in all 3 trials, and the steady state gain was 8.24 mmHg/STM. Based on these results, the proportional correction factor was set to 0.12, and the integral correction factor was set to 0.018. The computer simulation revealed that the system could quickly and effectively attenuate a sudden AP drop induced by external disturbances such as head-up tilting. Conclusion: An artificial baroreflex system with DBS may be a novel therapeutic approach for OH caused by central baroreflex failure.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.